Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Recognizing the link between certain autoimmune disorders and neurological conditions can improve diagnosis and treatment.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Alopecia areata involves immune response and gene changes affecting hair loss.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

A man's scalp hair loss was due to a combined melanocytic nevus and alopecia areata, suggesting a possible link between the two conditions.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

No single treatment is consistently effective for alopecia areata, and more research is needed.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.